Cargando…
Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients
Mucormycosis, also called “Black Fungus”, is a new cause for worry in the current Coronavirus disease 2019 (covid-19) pandemic. Mucormycosis is devasting due to its high rate of morbidity and mortality which is a great cause of concern. Mucormycosis, in general, affects immunocompromised patients in...
Autores principales: | Monika, P., Chandraprabha, M. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808276/ https://www.ncbi.nlm.nih.gov/pubmed/35107737 http://dx.doi.org/10.1007/s11033-022-07160-3 |
Ejemplares similares
-
Mucormycosis in an immunocompetent patient
por: Bharathi, Ramakrishnan, et al.
Publicado: (2012) -
Orbital mucormycosis in an immunocompetent individual
por: Badiee, P, et al.
Publicado: (2012) -
Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19
por: Sharma, Neelam, et al.
Publicado: (2022) -
A Case of Post-COVID-19 Rhino-Cerebral Mucormycosis in an Immunocompromised Patient
por: Faria, Labeeba, et al.
Publicado: (2023) -
Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic
por: Sharma, Ayushi, et al.
Publicado: (2022)